8 funds hold both · as on Jul 2026
Comparing mutual fund co-ownership helps identify hidden asset concentration. Our reverse lookup database shows that 8 mutual funds hold active equity positions in both Divi's Laboratories and Sudeep Pharma. The scheme with the highest combined exposure is SBI Healthcare Opportunities Fund (SBI MF), which holds a 7.46% stake in Divi's Laboratories and a 2.22% stake in Sudeep Pharma, amounting to a combined conviction weight of 9.68%.
When multiple mutual funds in your portfolio double-up on the same stock pairs, it limits your diversification benefits. If you also hold either of these companies directly in your demat account, your aggregate exposure is amplified. This co-ownership pattern is standard among index-tracking products but represents active, concentrated strategies in equity schemes.
These funds hold both stocks — see how much their entire portfolios overlap.
Check overlap of top funds →“Holds both” = the fund discloses an equity position in each stock in its latest public monthly portfolio (as on Jul 2026). Weight = the position as a % of that fund's portfolio. ISIN-verified from AMC disclosures. Not investment advice.